Reflow Medical announced the first six-month clinical results from a study of its Spur Elute sirolimus-eluting retrievable stent system.
San Clemente, California-based Reflow designed its...
EmStop announced that it kicked off the CAPTURE-2 FDA investigational device exemption (IDE) study of its embolic protection system (EPS).
CAPTURE-2 evaluates the safety and...
Reprieve Cardiovascular announced the publication of results from a pilot study of its heart failure therapy.
Milford, Massachusetts-based Reprieve Cardiovascular develops the Reprieve Therapy. It...
Medical Microinstruments (MMI) announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE study.
REMIND evaluates microsurgical intervention for neurodegenerative disease. MMI...
CVRx announced that it enrolled the first patient in its landmark BENEFIT-HF study of its Barostim therapy.
Barostim delivers electrical pulses to baroreceptors in the...
Sensome announced the publication of first-in-human results from the CLOT OUT study evaluating its Clotild smart guidewire system.
Findings published in the Journal of Neurointerventional...
CorTec GmbH announced that the first participant in the University of Washington’s NIH-funded clinical trial of the Brain Interchange™ BCI system has successfully controlled...
LivaNova has published 12-month data supporting its proximal hypoglossal nerve stimulation (pHGNS) system for sleep apnea.
Findings come from the OSPREY study, which London-based LivaNova...
FeelTect has kicked off a clinical trial in Ireland to evaluate its wearable, pressure-sensing device for vein ulcers.
Researchers at the University of Galway will...